Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label Study to Evaluate the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis Using an Electrochemiluminescent Immuno-Assay

NCT04740814 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT04740814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label Study to Evaluate the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis Using an Electrochemiluminescent Immuno-Assay
Lead sponsor
UCB Biopharma SRL
Phase
Phase 1
Overall status
Completed
Start date
February 11, 2021
Completion date
June 27, 2022
Enrollment
33 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis